Target- |
MechanismImmunostimulants |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismImmunostimulants |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with GENEART AG
0 Patents (Medical) associated with GENEART AG
100 Deals associated with GENEART AG
100 Translational Medicine associated with GENEART AG